D. E. Shaw & Co., Inc. Ampio Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $11,279 - $33,132	70,495 Added 138.55%	121,374 $20,000
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $467,908 - $690,722	-1,114,068 Reduced 95.63%	50,879 $24,000
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $418,054 - $1.28 Million	746,525 Added 178.41%	1,164,947 $664,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.8 $443,713 - $660,069	366,705 Added 709.06%	418,422 $695,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $80,678 - $102,399	51,717 New	51,717 $86,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.